KI2011 is a novel potent FLT3 tyrosine kinase inhibitor in acute myeloid leukemia cells with FLT3-mutation

被引：0
|
作者：
Ryu, Hwani [1 ]
Song, Jie-Young [1 ]
Ahn, Jiyeon [1 ]
机构：
[1] Korea Inst Radiol & Med Sci, Seoul, South Korea
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-806
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
806
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
    Green, Alexa S.
    Maciel, Thiago T.
    Hospital, Marie-Anne
    Yin, Chae
    Mazed, Fetta
    Townsend, Elizabeth C.
    Pilorge, Sylvain
    Lambert, Mireille
    Paubelle, Etienne
    Jacquel, Arnaud
    Zylbersztejn, Florence
    Decroocq, Justine
    Poulain, Laury
    Sujobert, Pierre
    Jacque, Nathalie
    Adam, Kevin
    So, Jason C. C.
    Kosmider, Olivier
    Auberger, Patrick
    Hermine, Olivier
    Weinstock, David M.
    Lacombe, Catherine
    Mayeux, Patrick
    Vanasse, Gary J.
    Leung, Anskar Y.
    Moura, Ivan C.
    Bouscary, Didier
    Tamburini, Jerome
    SCIENCE ADVANCES, 2015, 1 (08):
  • [22] AML, acute myeloid leukemia, FLT3 gene mutation Specific Features of the FLT3+Acute Myeloid Leukemia Course
    Radzhabova, Asiyat M.
    Martynkevich, Irina S.
    Motyko, Ekaterina V.
    Polushkina, Lubov B.
    Bakay, Marina P.
    Kuzyaeva, Anastasiya A.
    Voloshin, Sergey V.
    Potihonova, Nadezhda
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S228 - S229
  • [23] HEC73543 is a novel potent, selective Flt3 receptor tyrosine kinase (RTK) Inhibitor for the treatment of refractory acute myeloid leukemia (AML)
    Cheng, Cliff
    CANCER RESEARCH, 2017, 77
  • [24] Optimizing FLT3 Inhibitor Use in Adult Acute Myeloid Leukemia with FLT3 Mutations Using Proteomics
    Magalhaes, Eduardo Sabino
    Hubner, Stefan
    Brown, Brandon D.
    Qiu, Yihua
    Kornblau, Steven M.
    BLOOD, 2023, 142
  • [25] Tyrosine Kinase Inhibitor (TKI) Combination Scheduling Impacts Secondary FLT3 Tyrosine Kinase Domain (TKD) Mutation Profiles in a Xenograft Model of FLT3-ITD+ Acute Myeloid Leukemia (AML)
    van Oosterwijk, Jolieke G.
    Zimmerman, Eric I.
    Wang, Yong-Dong
    Orwick, Shelley
    Vasilyeva, Aksana
    Schuster, Katja
    Ramachandran, Abhijit
    Inaba, Hiroto
    Baker, Sharyn D.
    BLOOD, 2014, 124 (21)
  • [26] FLT3 Inhibition in Acute Myeloid Leukemia
    Smith, Catherine C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S5 - S6
  • [27] FLT3 inhibitors in acute myeloid leukemia
    Wu, Mei
    Li, Chuntuan
    Zhu, Xiongpeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [28] FLT3 inhibitors in acute myeloid leukemia
    Mei Wu
    Chuntuan Li
    Xiongpeng Zhu
    Journal of Hematology & Oncology, 11
  • [29] FLT3 Inhibitors in Acute Myeloid Leukemia
    Stone, Richard M.
    ONCOLOGIST, 2016, 21 : S2 - S2
  • [30] An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With FLT3-ITD Mutation, Treated With Gilteritinib, an FLT3 Inhibitor
    Kim, Ryan S.
    Yaghy, Antonio
    Wilde, Lindsay R.
    Shields, Carol L.
    JAMA OPHTHALMOLOGY, 2020, 138 (04) : 418 - 419
12345